期刊文献+

非对称二甲基精氨酸二甲胺水解酶-2的理论研究 被引量:2

Homology modeling of three-dimensional structure of dimethylarginine dimethylaminohydrolase-2(DDAH-2) and docking study on ligand
下载PDF
导出
摘要 利用同源模建的方法,构建了DDAH-2的三位结构.并与L-瓜氨酸、L-高半胱氨酸分别进行对接研究.其中,Asp77,Gly269,Glu27和Arg96是与L-瓜氨酸相互作用较强的残基,Asp77,His171,Asp125和Ala270是与L-高半胱氨酸相互作用较强的残基.尤其Asp77是在两种复合物中同时起重要作用的氨基酸,并且它与抑制剂之间都形成了氢键. Dimethylarginine dimethylaminohydrolase (DDAH) is involved in the regulation of nitric oxide synthase (NOS) .The structure of DDAH might be useful in the therapeutic treatment of NOS dysfunction-diseases .3D structure of DDAH-2 was modeled by using Homology. With the aid of the automated inolecular docking,the inhibition effect of L-citmlline and L-homocysteine for DDAH-2,respectively,were studied.By analyzing the structures of the enzyme in complex with L-citrulline,and L-homocysteine which has the lowest energy among the ten collected conformations,respectively,we know that the residues Asp77, Gly269, Glu27,Arg96 with L-citrulline,and the residues Asp77, His171, Asp125,Ala270 with L-homocysteine play an important role in the binding for the enzyme in complex, respectively. Asp77 is an important residues in beth complex,while it forms hydrogen bond to L-citrulline and L-homocysteine.
出处 《分子科学学报》 CAS CSCD 北大核心 2009年第2期116-120,共5页 Journal of Molecular Science
基金 黑龙江省自然科学基金资助项目(B200605) 黑龙江省博士后基金资助项目
  • 相关文献

参考文献11

二级参考文献25

  • 1Wang L Y Ji X. H Yuan H. et al.Acta Chimica Sinica(化学学报),2002,60:2115-2119. 被引量:1
  • 2Sominskaya I, Paulij W, Jansons J et al.. J. Immunol. Methods[J]. 2002, 260:251-261. 被引量:1
  • 3de Meyer S, Depla E, Maertens G et al.. J Viral. Hepatitis[J]. 1999, 6:277-285. 被引量:1
  • 4Mangold C M T, Streeck R E . J Virol.[J]. 1993, 67:4588-4597. 被引量:1
  • 5More V, Tromontaon A, Rustici M et al.. Biophys. Chem.[J]. 1997, 68:9-16. 被引量:1
  • 6InsightⅡ, Version 98.0[CP]. San Diego:MSI, 1998. 被引量:1
  • 7Ranganathan S, Simpson K J, Shaw D C et al.. J Mol. Graph. Model[J]. 1999, 17:106-113. 被引量:1
  • 8Jiang T, Xu Y, Zhang M Q Current Topic in Computational Molecular Biology[M]. Beijing:Tsinghua University Press, 2002:503-524. 被引量:1
  • 9Stirk H J, Thornton J M, Howard C R . Intervirology[J]. 1992, 33:148-158. 被引量:1
  • 10Gubernator K, Bhm H J . Structure-based Ligand Design[M]. New York:Wiley-VCH, 1998. 被引量:1

共引文献9

同被引文献26

  • 1Colasanti M, Suzuki H. The dual personality of NO. Trends Pharmacolog Sci, 2000, 21:249--252. 被引量:1
  • 2Tsao PS, Cooke JP. Endothelial alterations in hypercholesterolemia: more than simply vasodilator dysfunction. J Cardiovasc Pharmacol, 1998, 32(Suppl 3): S48-S53. 被引量:1
  • 3Vallance P, Leiper J. Blocking NO synthesis: How, where and why? Nature Reviews Drug Discovey, 2002, 1:939-950. 被引量:1
  • 4Leiper J, VaUance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res, 1999, 43: 542- 548. 被引量:1
  • 5Tran CT, Leiper JM, Vallance P. The DDAH/ADMA/NOS pathway. Atherosclerosis, 2003, 4(suppl.): 33-40. 被引量:1
  • 6Cooke JP. Asymmetrical dimethylarginine: The uber marker? Circulation, 2004, 109:1813-1818. 被引量:1
  • 7Vallance P, Leiper J. Cardiovascular biology of the asymmetric dimethylargiuine: Dimethylarginine dimethylaminohydrolase pathway. Vasc Biol, 2004, 24:1023-1030. 被引量:1
  • 8Frey D, Braun O, Briand C, Vasak M, Grtitter M. Structure of the mammalian NOS regulator dimethylarginine dimethylaminohydrolase: A basis for the design of specific inhibitors. Elsev Res, 2006, 14:901-911. 被引量:1
  • 9Kotthaus J, Schade D. Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: Alkenyl-amidines as new leads. Bioorg Med Chem, 2008, 16:10205--10209. 被引量:1
  • 10Insight, Version 98.0 [CP], San Diego: M S I, 1998. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部